Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-02-10 Sale |
2023-02-14 7:16 pm |
Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer |
4,500 | $10 | $45,005 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-06-23 4:16 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Hoitt Jason Chief Patient Officer |
0 | $0 | 521,802 (Direct) |
View |
2023-01-10 Option Award |
2023-01-11 9:10 pm |
N/A 2033-01-10 |
Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2022-12-08 Option Award |
2022-12-09 8:31 pm |
2022-12-08 2030-01-07 |
Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer |
140,663 | $0 | 415,763 (Direct) |
View |
2022-01-18 Option Award |
2022-01-20 5:20 pm |
N/A 2032-01-18 |
Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer |
145,000 | $0 | 145,000 (Direct) |
View |
2021-05-12 Option Award |
2021-05-14 7:39 pm |
N/A 2031-05-12 |
Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer |
139,500 | $0 | 139,500 (Direct) |
View |